Skip to content
← Back to this collection

PUBLICATIONS · 9164205

Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1997 May
First author
Bolis G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Bolis G
      type
      Author
    2. name
      Favalli G
      type
      Author
    3. name
      Danese S
      type
      Author
    4. name
      Zanaboni F
      type
      Author
    5. name
      Mangili G
      type
      Author
    6. name
      Scarabelli C
      type
      Author
    7. name
      Tateo S
      type
      Author
    8. name
      Valsecchi MG
      type
      Author
    9. name
      Scarfone G
      type
      Author
    10. name
      Richiardi G
      type
      Author
    11. name
      Frigerio L
      type
      Author
    12. name
      Melpignano M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Bolis G
      type
      Author
    2. name
      Favalli G
      type
      Author
    3. name
      Danese S
      type
      Author
    4. name
      Zanaboni F
      type
      Author
    5. name
      Mangili G
      type
      Author
    6. name
      Scarabelli C
      type
      Author
    7. name
      Tateo S
      type
      Author
    8. name
      Valsecchi MG
      type
      Author
    9. name
      Scarfone G
      type
      Author
    10. name
      Richiardi G
      type
      Author
    11. name
      Frigerio L
      type
      Author
    12. name
      Melpignano M
      type
      Author
    bibliography ids
    1. nci-bib-085eb0ca01e5be56a93c59cd
    book metadata
    content sha256
    68d025caa43aa2fe814321a2fc23bc8c21e5d85d13034bb7769a8059fd162bad
    document type
    citation
    dois
    1. 10.1200/JCO.1997.15.5.1938
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:9164205
    immutable id
    pubmed:9164205@68d025caa43aa2fe814321a2fc23bc8c21e5d85d13034bb7769a8059fd162bad
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    5
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1938-44
    volume
    15
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      9164205
      provenance
      batch id
      629590480cca3a097fa8
      provider
      NCBI PubMed ESummary
      record sha256
      1a4ffea83721455c85d1a6b51ee2556f5b0bda41159cc1e071dc7041903ffa98
      response sha256
      0eb1cec7011436204408643f1cea7888e97d436038d0a09eaecfd9b32db84919
      retrieved at
      2026-09-09T23:45:26.993225+00:00
      publication date
      display
      1997 May
      precision
      month
      year
      1997
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/9164205/
      title
      Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.

      Preserved source evidence · Not medical advice